Navigation Links
Jackson Lewis to Support Presagia's Integrated Absence & Disability Management Solution
Date:2/28/2008

MONTREAL, Feb. 28 /PRNewswire/ -- Jackson Lewis LLP, a leading U.S. workplace law firm and Presagia Corporation, a leading provider of health and productivity management solutions, today announced the signing of an agreement that will see Jackson Lewis assist Presagia with the development of its workforce absence and disability software solutions.

According to David Glickman, Presagia's CEO, "Integrated absence and disability management is widely regarded as an effective strategy to reduce lost-time costs for U.S. employers, currently estimated to be 15% of payroll and growing. Through comprehensive, standardized management and documentation of all leave cases and appropriate escalation of potential high-cost cases, employers can target the primary absence drivers and minimize related health, productivity and legal compliance costs."

"We're very excited to be working with Presagia on this initiative," explains Frank Alvarez, national coordinator for Jackson Lewis' Disability, Leave and Health Management practice group. "Leave management and benefit administration have grown increasingly complex. Employers seem to be starving for tools to help them manage attendance and productivity more effectively. To make good employment decisions that reduce the risk of employment litigation, employers must identify and respect employee eligibility for job-protected leaves; they also must efficiently capture and communicate information about employee medical conditions and absences. Presagia's software will help fulfill those employer needs and we are pleased to be a part of that effort."

While Presagia's technology is not a legal service, and no attorney-client relationship is formed by its purchase or use, Jackson Lewis will help Presagia develop the workflow, rules, documentation and decision support required for compliance and litigation support.

In addition to enhancing workplace compliance efforts and providing accurate and complete docume
'/>"/>

SOURCE Presagia Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. First in Nation: notMYkid Educational Center Is Now a Reality Thanks to a Partnership Between Chrysler, Barrett-Jackson and notMYkid
2. CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville
3. Randy Jackson Takes Aim at Diabetes
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
6. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
7. IncentOnes Sue Lewis brings "The Art and Science of Incentive Management" to AHIP Business Forum
8. Jerry Lewis Urges Congress to Protect Medicare Benefits of People With Neuromuscular Diseases
9. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
10. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
11. ISS and Glass Lewis Recommend Cholestech Stockholders Vote FOR Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- Polio is history ... places like Afghanistan, Nigeria and Pakistan. Giving vaccinated children ... their immunity and help eradicate the highly infectious disease, ... is highly effective, immunity wanes as early as a ... be infected and contribute to the spread of the ...
(Date:7/11/2014)... breast cancer patients, the era of personalized medicine may ... by USC Stem Cell researcher Min Yu and scientists ... In a July 11 study in Science , ... cancer cells circulating through the blood streams of six ... "seeds" of metastasis, which travel to and establish secondary ...
(Date:7/11/2014)... FL (PRWEB) July 11, 2014 American ... on RFD-TV, next Tuesday, July 15, 2014, at 8:30 ... Sunbelt's line of proprietary products, which are designed and ... crops. Audiences will learn how these products help the ... environment in which it is grown. , The show ...
(Date:7/11/2014)... Shoulder instability is a common injury in ... has not been regularly determined following surgery. A new ... Medicine’s ( AOSSM ) Annual Meeting today details that ... no matter what the stabilization procedure (open vs. arthroscopic). ... to play following shoulder stabilization surgery. Age, number of ...
(Date:7/11/2014)... Anterior Cruciate Ligament (ACL) reconstructions occur more ... material used to create a new ligament may determine ... presenting their work today at the Annual Meeting of ... ). , “Our study results highlight that ... a donor) fail more frequently than using autografts (tissue ...
Breaking Medicine News(10 mins):Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL Reconstructions May Last Longer With Autografts 2
... , SINGAPORE, Nov. 16 /PRNewswire-Asia/ ... Malaysia grew steadily in the first half of 2009 with,total ... promotions from major Contact Lens manufacturers. Positive sales,data showing a ... view of an economic recovery that is being led by ...
... ... Critical Strategies for Successful Interactions Between Life Science Companies and Health Care Providers ... ... sales enablement and IT consulting company, today announced that UCB, a global biopharmaceutical ...
... ... Kids who Wear Ankle-Foot Orthoses (AFOs) , ... Westchester, NY (PRWEB) November 16, 2009 -- Ross Daniel Adaptive Apparel ... and the launch of “Cool Clothes for Toes,” the first creatively styled sock line for ...
... NANJING, China, Nov. 16 /PRNewswire-Asia/ -- Simcere Pharmaceutical ... pharmaceutical company,specializing in the development, manufacturing, and marketing of branded,generic and ... ended September 30, 2009. , , Highlights, ... the third, quarter of 2009, ...
... , Study highlights: , In patients with or ... treated with statins to < 100mg/dL but low HDL (good ... LDL further. , Patients were randomized to the addition of ... LDL cholesterol). Plaque buildup in the lining of the ...
... ... to begin the drug registration process in Brazil and Colombia for its over-the-counter pain ... for the treatment of moderate to severe (Stage 2) chronic pain. , ... Plantation, FL (Vocus) November 15, ...
Cached Medicine News:Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 3Health News:Leading Biopharmaceutical Company Selects Stimar for Code of Conduct Regulation Training 2Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 2Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 3Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results 12Health News:American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up 2Health News:American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up 3Health News:American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up 4Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 2Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 3Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 4
(Date:7/11/2014)...  Kindred Hospital Houston Northwest, with Wound Care ... its new outpatient wound healing center.  The wound ... chronic, hard to heal wounds. Chronic wounds include ... lower leg wounds related to blood flow issues, ... injury wounds which are complex and demonstrate delayed ...
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery company, ... it has raised A$19.3 million via a placement of ... , the U.S., Asia ... from a share purchase plan (SPP) to be offered ... be made in two tranches. "This capital ...
(Date:7/11/2014)... July 11, 2014 On ... down 0.52%, the Dow Jones Industrial Average finished the day ... 1,964.68, down 0.41%. The losses were broad based as eight ... S&P 500 Health Care Sector Index ended the day at ... the last one month. Investor-Edge has initiated coverage on the ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
... is largely a collaborative enterprise. Frequently researchers from ... their efforts and exchange ideas, to devise new ... as those known as autism spectrum disorders, researchers ... diverse populations of patients, finding a broader pool ...
... AZOR Using 24-Hour Ambulatory BP MeasuresPARSIPPANY, N.J., May 8 ... at the American Society of Hypertension, Inc. (ASH) Twenty-Fourth ... Francisco from the AZ OR(R) T rial ... ontrol ( AZTEC ) demonstrated that a stepwise amlodipine ...
Cached Medicine Technology:Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 2Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 3Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 4New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 2New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 3New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 4New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 5New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 6New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 7New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 8New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 9
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
Medicine Products: